NYSE:TMO - New York Stock Exchange, Inc. - US8835561023 - Common Stock - Currency: USD
THERMO FISHER SCIENTIFIC INC
NYSE:TMO (2/5/2025, 11:49:10 AM)
578.945
-1.62 (-0.28%)
The current stock price of TMO is 578.945 USD. In the past month the price increased by 9.13%. In the past year, price increased by 5.41%.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
DHR | DANAHER CORP | 28.51 | 154.26B | ||
A | AGILENT TECHNOLOGIES INC | 27.98 | 42.22B | ||
IQV | IQVIA HOLDINGS INC | 18.78 | 37.02B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 35.9 | 28.90B | ||
WAT | WATERS CORP | 36.36 | 24.59B | ||
WST | WEST PHARMACEUTICAL SERVICES | 49.15 | 24.06B | ||
ILMN | ILLUMINA INC | 73.24 | 20.09B | ||
ICLR | ICON PLC | 14.02 | 16.24B | ||
RVTY | REVVITY INC | 25.28 | 15.07B | ||
AVTR | AVANTOR INC | 22.55 | 15.04B | ||
TECH | BIO-TECHNE CORP | 42.77 | 12.16B | ||
MEDP | MEDPACE HOLDINGS INC | 30.78 | 10.92B |
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. The company is headquartered in Waltham, Massachusetts and currently employs 122,000 full-time employees. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. The company also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
THERMO FISHER SCIENTIFIC INC
168 Third Avenue
Waltham MASSACHUSETTS 02451 US
CEO: Marc N. Casper
Employees: 122000
Company Website: https://www.thermofisher.com/
Investor Relations: https://ir.thermofisher.com
Phone: 17816221000
The current stock price of TMO is 578.945 USD.
The exchange symbol of THERMO FISHER SCIENTIFIC INC is TMO and it is listed on the New York Stock Exchange, Inc. exchange.
TMO stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TMO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TMO.
TMO has a dividend yield of 0.26%. The yearly dividend amount is currently 1.52.
The PE ratio for TMO is 26.48. This is based on the reported non-GAAP earnings per share of 21.86 and the current share price of 578.945 USD.
The outstanding short interest for TMO is 0.91% of its float.
ChartMill assigns a technical rating of 7 / 10 to TMO. When comparing the yearly performance of all stocks, TMO turns out to be only a medium performer in the overall market: it outperformed 61.19% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to TMO. While TMO has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months TMO reported a non-GAAP Earnings per Share(EPS) of 21.86. The EPS increased by 1.49% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.78% | ||
ROA | 6.51% | ||
ROE | 12.79% | ||
Debt/Equity | 0.59 |
ChartMill assigns a Buy % Consensus number of 82% to TMO. The Buy consensus is the average rating of analysts ratings from 37 analysts.
For the next year, analysts expect an EPS growth of 6.72% and a revenue growth 3.08% for TMO